Silverfin false 31/12/2022 31/12/2022 01/01/2022 The principal activity of the Company during the financial year was that of the manufacture and sale of a hair dye allergy test. Dr C Hamman 12/11/2019 R Hodkinson 12/11/2019 N Plunkett 18/12/2013 04091037 2022-12-31 04091037 bus:Director1 2022-12-31 04091037 bus:Director2 2022-12-31 04091037 bus:Director3 2022-12-31 04091037 2021-12-31 04091037 core:CurrentFinancialInstruments 2022-12-31 04091037 core:CurrentFinancialInstruments 2021-12-31 04091037 core:Non-currentFinancialInstruments 2022-12-31 04091037 core:Non-currentFinancialInstruments 2021-12-31 04091037 2022-01-01 2022-12-31 04091037 bus:Micro-entities 2022-01-01 2022-12-31 04091037 bus:FullAccounts 2022-01-01 2022-12-31 04091037 bus:AuditExemptWithAccountantsReport 2022-01-01 2022-12-31 04091037 bus:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 04091037 bus:Director1 2022-01-01 2022-12-31 04091037 bus:Director2 2022-01-01 2022-12-31 04091037 bus:Director3 2022-01-01 2022-12-31 04091037 2021-01-01 2021-12-31 iso4217:GBP xbrli:pure

Company No: 04091037 (England and Wales)

TRICHOCARE DIAGNOSTICS LTD

Unaudited Financial Statements
For the financial year ended 31 December 2022
Pages for filing with the registrar

TRICHOCARE DIAGNOSTICS LTD

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 December 2022

Contents

TRICHOCARE DIAGNOSTICS LTD

COMPANY INFORMATION

For the financial year ended 31 December 2022
TRICHOCARE DIAGNOSTICS LTD

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2022
DIRECTORS Dr C Hamman
R Hodkinson
N Plunkett
REGISTERED OFFICE Finsgate
5-7 Cranwood Street
London
EC1V 9EE
United Kingdom
COMPANY NUMBER 04091037 (England and Wales)
ACCOUNTANT Gravita Business Services Limited
Finsgate
5-7 Cranwood Street
London
EC1V 9EE
United Kingdom

ACCOUNTANT'S REPORT TO THE BOARD OF DIRECTORS
ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF TRICHOCARE DIAGNOSTICS LTD

For the financial year ended 31 December 2022

ACCOUNTANT'S REPORT TO THE BOARD OF DIRECTORS
ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF TRICHOCARE DIAGNOSTICS LTD (continued)

For the financial year ended 31 December 2022

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Trichocare Diagnostics Ltd for the financial year ended 31 December 2022 which comprise the Balance Sheet and the related notes from the Company’s accounting records and from information and explanations you have given us.

We are subject to the ethical and other professional requirements of the Institute of Chartered Accountants in England and Wales (ICAEW) which are detailed at _http://www.icaew.com/en/members/regulations-standards-and-guidance_.

It is your duty to ensure that Trichocare Diagnostics Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Trichocare Diagnostics Ltd. You consider that Trichocare Diagnostics Ltd is exempt from the statutory audit requirement for the financial year.

We have not been instructed to carry out an audit or a review of the financial statements of Trichocare Diagnostics Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

This report is made solely to the Board of Directors of Trichocare Diagnostics Ltd, as a body, in accordance with the terms of our engagement letter dated 22 March 2021. Our work has been undertaken solely to prepare for your approval the financial statements of Trichocare Diagnostics Ltd and state those matters that we have agreed to state to the Board of Directors of Trichocare Diagnostics Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Trichocare Diagnostics Ltd and its Board of Directors as a body for our work or for this report.

Gravita Business Services Limited
Accountant

Finsgate
5-7 Cranwood Street
London
EC1V 9EE
United Kingdom

24 November 2023

TRICHOCARE DIAGNOSTICS LTD

BALANCE SHEET

As at 31 December 2022
TRICHOCARE DIAGNOSTICS LTD

BALANCE SHEET (continued)

For the financial year ended 31 December 2022
2022 2021
£ £
Fixed assets 29,940 42,709
Current assets 264,306 342,136
Prepayments and accrued income 15,294 14,132
Creditors: amounts falling due within one year ( 201,829) ( 74,650)
Net current assets 77,771 281,618
Total assets less current liabilities 107,711 324,327
Creditors: amounts falling due after more than one year ( 1,722,515) ( 1,281,399)
Accruals and deferred income ( 107,103) ( 57,615)
Net liabilities ( 1,721,907) ( 1,014,687)
Capital and reserves ( 1,721,907) ( 1,014,687)

For the financial year ending 31 December 2022 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Trichocare Diagnostics Ltd (registered number: 04091037) were approved and authorised for issue by the Board of Directors on 24 November 2023 and were signed on its behalf by:

N Plunkett
Director
TRICHOCARE DIAGNOSTICS LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2022
TRICHOCARE DIAGNOSTICS LTD

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 December 2022

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 04091037). The address of its registered office is Finsgate, 5-7 Cranwood Street, London, EC1V 9EE, United Kingdom.

2. Employees

2022 2021
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 7 8

3. Directors’ benefits: advances, credit and guarantees

Advances

Included within current assets is a total directors loan of £70,248 owed from directors (2021: £68,654). The amount is repayable on demand and interest free.

4. Guarantees and other financial commitments

Pensions

The Company operates a defined contribution pension scheme for the directors and senior employees. The assets of the scheme are held separately from those of the Company in an independently administered fund.

2022 2021
£ £
Unpaid contributions due to the fund (inc. in other creditors) 1,306 605

The Company has granted a floating charge over its assets to secure loans.

5. Going Concern

The directors note that the Company is loss making and in a net liabilities position. The Company is primarily funded through cash advances from shareholders and the directors have received confirmation that the shareholders will not request a repayment of the cash advances within 12 months of signing these financial statements, unless the Company has the ability to do so. The directors have secured further funds from its shareholders post year end. The shareholders have confirmed to financially support the business as required for a minimum period of 12 months from the date of these financial statements being signed and that they have the funds to do so. Based on the above and the financial support from the shareholders, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.